Table 1.
General characteristics of study subjects, 2012–2015
| Characteristic | 2012 (N = 579) n (%) | 2013 (N = 433) n (%) | 2014 (N = 340) n (%) | 2015 (N = 420) n (%) | All years (N = 1772) n (%) |
|---|---|---|---|---|---|
| Age group (years) a | |||||
| 0–14 | 43 (7.4) | 22 (5.1) | 13 (3.8) | 9 (2.1) | 87 (4.9) |
| 15–29 | 98 (16.9) | 69 (15.9) | 49 (14.4) | 60 (14.3) | 276 (15.6) |
| 30–49 | 240 (41.5) | 179 (41.3) | 154 (45.3) | 179 (42.6) | 752 (42.4) |
| 50–69 | 132 (22.8) | 116 (26.8) | 93 (27.4) | 122 (29.1) | 463 (26.1) |
| ≥ 70 | 66 (11.4) | 47 (10.9) | 31 (9.1) | 48 (11.4) | 192 (10.9) |
| Sex | |||||
| Male | 374 (64.6) | 276 (63.7) | 221 (65.0) | 296 (70.5) | 1167 (65.9) |
| Female | 205 (35.4) | 157 (36.3) | 119 (35.0) | 124 (29.5) | 605 (34.1) |
| Patient category b | |||||
| New | 547 (94.5) | 393 (90.8) | 322 (94.7) | 375 (89.3) | 1637 (92.4) |
| Transferred in | 1 (0.2) | 3 (0.7) | 1 (0.3) | 0 | 5 (0.3) |
| Return after default | 5 (0.9) | 3 (0.7) | 1 (0.3) | 7 (1.7) | 16 (0.9) |
| Treatment failure | 4 (0.7) | 9 (2.1) | 5 (1.5) | 12 (2.9) | 30 (1.7) |
| Relapse | 6 (1.0) | 11 (2.5) | 10 (2.9) | 12 (2.9) | 39 (2.2) |
| Other | 15 (2.6) | 15 (3.2) | 1 (0.3) | 3 (0.7) | 33 (1.9) |
| TB classification c | |||||
| Pulmonary positive | 262 (45.3) | 240 (55.4) | 224 (65.9) | 299 (71.2) | 1025 (57.8) |
| Pulmonary negative | 279 (48.2) | 183 (42.3) | 109 (32.1) | 101 (24.1) | 672 (37.9) |
| Extra-pulmonary | 37 (6.4) | 10 (2.3) | 7 (2.1) | 12 (2.9) | 66 (3.7) |
| Treatment District | |||||
| Ho | 194 (33.5) | 123 (28.4) | 67 (19.7) | 64 (15.2) | 448 (25.3) |
| Hohoe | 127 (21.9) | 97 (22.4) | 95 (27.9) | 76 (18.1) | 395 (22.3) |
| Kadjebi | 51 (8.8) | 91 (21.0) | 43 (12.7) | 90 (21.4) | 275 (15.5) |
| Keta | 118 (20.4) | 47 (10.9) | 53 (15.6) | 101 (26.0) | 327 (18.5) |
| Kpando | 89 (15.4) | 75 (17.3) | 82 (24.1) | 81 (19.3) | 327 (18.5) |
Missing values for agea, patient categoryb, and TB classificationc; 2 (0.1%); 12 (0.7%); and 9 (0.5%) respectively